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Penicillinase-producingNeisseria gonorrhoeae (PPNG) carrying the blaTEM-135 gene is of particular concern, as it is considered a
stepping stone toward resistance to extended-spectrum cephalosporins. Here, we sought to characterize plasmid types and the
occurrence of the blaTEM-135 gene forN. gonorrhoeae clinical isolates from Australia. We found that blaTEM-135 was prevalent in
Australian PPNG and was detected on all three major plasmid types.
High-level resistance to penicillin in Neisseria gonorrhoeae isconferred by plasmid-mediated penicillinase production. To
date, seven different penicillinase-harboring gonococcal plasmid
types have been described and comprise three main plasmid types
(Asian, African, and Rio/Toronto plasmids) and four less com-
mon variants (Nimes, New Zealand, Johannesburg, and Austra-
lian plasmids) (1–7). There are two different penicillinase genes
that may be carried by these plasmids, including the classical blaTEM-1
gene and the more recently described gonococcal blaTEM-135 gene
(8). The blaTEM-135 gene is of concern as it is considered to be an
intermediate between a penicillinase and an extended-spec-
trum -lactamase (9) and is therefore considered a potential
future threat to the effectiveness of N. gonorrhoeae treatment.
The blaTEM-135 gene was first described in an isolate from Thailand
(8) and has since been reported in various countries, including
Canada (10), China (11), Japan (12), and Switzerland (13). How-
ever, there are now more recent data showing that blaTEM-135 has
been present in gonococci since at least 1984, suggesting that the
gene is not, as originally thought, a recent evolutionary event
driven by selective pressure through the use of extended-spectrum
cephalosporins (14).
Data on the rate at which penicillinase-producing N. gonor-
rhoeae (PPNG) isolates carry the blaTEM-135 gene are limited, rang-
ing from 9.4% (9/96 PPNG isolates) in Thailand (9) and 20%
(2/10 PPNG isolates) in Japan (12) to 58% (66/114 PPNG isolates)
in China (11). These studies also highlighted that blaTEM-135 may
occur in distinct genetic backgrounds and suggested that the gene
has continued to be shared among gonococci via horizontal ge-
netic exchange, having been found on the Asian and Rio/Toronto
plasmid types and across various multilocus sequence types
(MLST) and N. gonorrhoeae multiantigen sequence types (NG-
MAST) (8, 11, 12, 14).
In this study, we sought to characterize plasmid types and the
occurrence of the blaTEM-135 gene in N. gonorrhoeae clinical iso-
lates from Australia. A total of 351 PPNG clinical isolates were
included in this study (Table 1). These were all PPNG isolates
identified as part of a broader investigation of N. gonorrhoeae iso-
lates (n 2,455) that were collected from throughout Australia in
the first half of the year 2012 (7, 15). The isolates were initially
determined to be PPNG on the basis of acidometric and nitrocefin
disc testing and subsequently by real-time PCR (7). The DNA used
for the real-time PCR testing was stored at 80°C until further
investigation. Here, the DNA from these PPNG isolates was tested
by a plasmid typing method that enables differentiation of the
three main plasmid types, Asian, African, and Rio/Toronto, via
conventional PCR and agarose gel electrophoresis detection (16).
Plasmid types were assigned for 327 isolates (Table 1), and no
amplification products were observed for the remaining 24 iso-
lates; these 24 isolates were excluded from further analysis. Over-
all, the African plasmid type was most common, comprising 237/
327 isolates (72.5%), followed by the Rio/Toronto (n  47;
14.4%) and the Asian (n  43; 13.1%) plasmids. (It should be
noted that the 47 Rio/Toronto plasmids included a single isolate
with the recently described “Australian plasmid”—a variant of the
Rio/Toronto plasmid that we described in our preliminary inves-
tigations [7]. The plasmid typing method does not differentiate
such variants.)
The 327 isolates were then investigated for the blaTEM-135 allele
using a previously described allele-specific PCR method (9). The
results of this testing showed that 90 (27.5%) of the 327 PPNG
isolates harbored blaTEM-135 and comprised all 47 (100%) of the
Rio/Toronto plasmids, 23/43 (53.5%) of the Asian plasmids, and
20/237 (8.4%) of the African plasmids. These 90 isolates were
further genotyped by single nucleotide polymorphism (SNP)-
based MLST (17), and 23 different sequence types (STs) were ob-
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served for 89 isolates (one isolate could not be typed by the SNP
MLST method) (Table 2). All the isolates with the African plasmid
harboring blaTEM-135 (n  20) were a single ST (ST1600; Table 2),
whereas the Asian and Rio/Toronto plasmids harboring blaTEM-135
comprised 5 and 17 different STs, respectively. Of note was that six of
the plasmid type/ST combinations observed in our population had
previously been observed in studies of blaTEM-135 in Japan and Thai-
land, which is consistent with international transmission of these
strains. Of further interest was that the Rio/Toronto plasmids carried
only the blaTEM-135 gene and not the blaTEM-1 gene. This adds further
weight to the suggestion by Muhammad et al. (14) that the Rio/To-
ronto plasmids are the origin of blaTEM-135 in gonococci.
In summary, the blaTEM-135 gene was commonplace in this
sample of Australian PPNG isolates, was detected on all three ma-
jor plasmid types, was consistent with previous studies, and was
found across genetically distinct clonal groups. These data provide
further evidence of the broad distribution and ongoing spread of
the blaTEM-135 gene among gonococci.
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